102 research outputs found
Anwendungen maschinellen Lernens für datengetriebene Prävention auf Populationsebene
Healthcare costs are systematically rising, and current therapy-focused healthcare systems are not sustainable in the long run. While disease prevention is a viable instrument for reducing costs and suffering, it requires risk modeling to stratify populations, identify high- risk individuals and enable personalized interventions. In current clinical practice, however, systematic risk stratification is limited: on the one hand, for the vast majority of endpoints, no risk models exist. On the other hand, available models focus on predicting a single disease at a time, rendering predictor collection burdensome. At the same time, the den- sity of individual patient data is constantly increasing. Especially complex data modalities, such as -omics measurements or images, may contain systemic information on future health trajectories relevant for multiple endpoints simultaneously. However, to date, this data is inaccessible for risk modeling as no dedicated methods exist to extract clinically relevant information. This study built on recent advances in machine learning to investigate the ap- plicability of four distinct data modalities not yet leveraged for risk modeling in primary prevention. For each data modality, a neural network-based survival model was developed to extract predictive information, scrutinize performance gains over commonly collected covariates, and pinpoint potential clinical utility. Notably, the developed methodology was able to integrate polygenic risk scores for cardiovascular prevention, outperforming existing approaches and identifying benefiting subpopulations. Investigating NMR metabolomics, the developed methodology allowed the prediction of future disease onset for many common diseases at once, indicating potential applicability as a drop-in replacement for commonly collected covariates. Extending the methodology to phenome-wide risk modeling, elec- tronic health records were found to be a general source of predictive information with high systemic relevance for thousands of endpoints. Assessing retinal fundus photographs, the developed methodology identified diseases where retinal information most impacted health trajectories. In summary, the results demonstrate the capability of neural survival models to integrate complex data modalities for multi-disease risk modeling in primary prevention and illustrate the tremendous potential of machine learning models to disrupt medical practice toward data-driven prevention at population scale.Die Kosten im Gesundheitswesen steigen systematisch und derzeitige therapieorientierte Gesundheitssysteme sind nicht nachhaltig. Angesichts vieler verhinderbarer Krankheiten stellt die Prävention ein veritables Instrument zur Verringerung von Kosten und Leiden dar. Risikostratifizierung ist die grundlegende Voraussetzung für ein präventionszentri- ertes Gesundheitswesen um Personen mit hohem Risiko zu identifizieren und Maßnah- men einzuleiten. Heute ist eine systematische Risikostratifizierung jedoch nur begrenzt möglich, da für die meisten Krankheiten keine Risikomodelle existieren und sich verfüg- bare Modelle auf einzelne Krankheiten beschränken. Weil für deren Berechnung jeweils spezielle Sets an Prädiktoren zu erheben sind werden in Praxis oft nur wenige Modelle angewandt. Gleichzeitig versprechen komplexe Datenmodalitäten, wie Bilder oder -omics- Messungen, systemische Informationen über zukünftige Gesundheitsverläufe, mit poten- tieller Relevanz für viele Endpunkte gleichzeitig. Da es an dedizierten Methoden zur Ex- traktion klinisch relevanter Informationen fehlt, sind diese Daten jedoch für die Risikomod- ellierung unzugänglich, und ihr Potenzial blieb bislang unbewertet. Diese Studie nutzt ma- chinelles Lernen, um die Anwendbarkeit von vier Datenmodalitäten in der Primärpräven- tion zu untersuchen: polygene Risikoscores für die kardiovaskuläre Prävention, NMR Meta- bolomicsdaten, elektronische Gesundheitsakten und Netzhautfundusfotos. Pro Datenmodal- ität wurde ein neuronales Risikomodell entwickelt, um relevante Informationen zu extra- hieren, additive Information gegenüber üblicherweise erfassten Kovariaten zu quantifizieren und den potenziellen klinischen Nutzen der Datenmodalität zu ermitteln. Die entwickelte Me-thodik konnte polygene Risikoscores für die kardiovaskuläre Prävention integrieren. Im Falle der NMR-Metabolomik erschloss die entwickelte Methodik wertvolle Informa- tionen über den zukünftigen Ausbruch von Krankheiten. Unter Einsatz einer phänomen- weiten Risikomodellierung erwiesen sich elektronische Gesundheitsakten als Quelle prädik- tiver Information mit hoher systemischer Relevanz. Bei der Analyse von Fundusfotografien der Netzhaut wurden Krankheiten identifiziert für deren Vorhersage Netzhautinformationen genutzt werden könnten. Zusammengefasst zeigten die Ergebnisse das Potential neuronaler Risikomodelle die medizinische Praxis in Richtung einer datengesteuerten, präventionsori- entierten Medizin zu verändern
2023- The Twenty-seventh Annual Symposium of Student Scholars
The full program book from the Twenty-seventh Annual Symposium of Student Scholars, held on April 18-21, 2023. Includes abstracts from the presentations and posters.https://digitalcommons.kennesaw.edu/sssprograms/1027/thumbnail.jp
Detection Of Malaria Parasites In Human Blood Cells Using Convolutional Neural Network
Malaria is a blood disease caused by the Plasmodium parasite which is transmitted by the bite of the female Anopheles mosquito. The diagnosis of malaria is carried out by a microscopist through examination of human blood cells. Their level of accuracy depends on the quality of the tool, expertise in classifying and counting infected and uninfected parasite cells. The disadvantages of examining this way include the difficulty in making a diagnosis on a large scale and the poor quality of the results. The dataset used in model evaluation is a dataset developed by LHNVBC which contains 27,558 cell image data. The malaria dataset will be processed through data science processing using a Convolutional Neural Network with the ResNet architecture. The model will conduct training on the dataset and then the model will be able to recognize malaria parasites in human blood cells. The model will be trained by optimizing multinomial logistic regression using Stochastic Gradient Descent (SGD) and Nesterov momentum values. The results of training data validation accuracy from model training with 50 epochs were obtained at 96.23% and 97% after being tested on data testing
Artificial Intelligence in Image-Based Screening, Diagnostics, and Clinical Care of Cardiopulmonary Diseases
Cardiothoracic and pulmonary diseases are a significant cause of mortality and morbidity worldwide. The COVID-19 pandemic has highlighted the lack of access to clinical care, the overburdened medical system, and the potential of artificial intelligence (AI) in improving medicine. There are a variety of diseases affecting the cardiopulmonary system including lung cancers, heart disease, tuberculosis (TB), etc., in addition to COVID-19-related diseases. Screening, diagnosis, and management of cardiopulmonary diseases has become difficult owing to the limited availability of diagnostic tools and experts, particularly in resource-limited regions. Early screening, accurate diagnosis and staging of these diseases could play a crucial role in treatment and care, and potentially aid in reducing mortality. Radiographic imaging methods such as computed tomography (CT), chest X-rays (CXRs), and echo ultrasound (US) are widely used in screening and diagnosis. Research on using image-based AI and machine learning (ML) methods can help in rapid assessment, serve as surrogates for expert assessment, and reduce variability in human performance. In this Special Issue, “Artificial Intelligence in Image-Based Screening, Diagnostics, and Clinical Care of Cardiopulmonary Diseases”, we have highlighted exemplary primary research studies and literature reviews focusing on novel AI/ML methods and their application in image-based screening, diagnosis, and clinical management of cardiopulmonary diseases. We hope that these articles will help establish the advancements in AI
Classification of Microscopic Malaria Parasitized Images Using Deep Learning Feature Fusion
An infectious disease that causes a chronic and potentially life-threatening infection caused by microorganisms of the Plasmodium class, is malaria, or malarial disease. It is critical to detect the presence of Malaria parasites as early as possible to ensure that antimalarial treatment is adequate to cure the particular type of Plasmodium. This is to reduce death rates and to focus on various infections in the event of an adverse outcome. The purpose of this study was to develop an artificial intelligence approach capable of separating parasitized erythrocytes from normal basophilic erythrocytes as well as platelets overlying the red blood cells to overcome the high cost of Ma-laria diagnostic equipment. The tone and texture characteristics of erythrocyte images were extracted using histo-gram thresholds and watershed methods, and then fused with Squeeze Net and ShuffleNet algorithms. The measures included planning, preparing, approving, and testing Deep Convolution Neural Network Segmentation without preparation using a graphic processor unit. A total of 96 percent accuracy and specificity was obtained for the position of malaria in red blood cells based on the results of all of the tests. It has been demonstrated that deep learning can be effective in the field of clinical pathology. This provides new directions for development as well as increasing awareness of researchers in this field
Chapter 34 - Biocompatibility of nanocellulose: Emerging biomedical applications
Nanocellulose already proved to be a highly relevant material for biomedical
applications, ensued by its outstanding mechanical properties and, more importantly, its biocompatibility. Nevertheless, despite their previous intensive
research, a notable number of emerging applications are still being developed.
Interestingly, this drive is not solely based on the nanocellulose features, but also
heavily dependent on sustainability. The three core nanocelluloses encompass
cellulose nanocrystals (CNCs), cellulose nanofibrils (CNFs), and bacterial nanocellulose (BNC). All these different types of nanocellulose display highly interesting biomedical properties per se, after modification and when used in
composite formulations. Novel applications that use nanocellulose includewell-known areas, namely, wound dressings, implants, indwelling medical
devices, scaffolds, and novel printed scaffolds. Their cytotoxicity and biocompatibility using recent methodologies are thoroughly analyzed to reinforce their
near future applicability. By analyzing the pristine core nanocellulose, none
display cytotoxicity. However, CNF has the highest potential to fail long-term
biocompatibility since it tends to trigger inflammation. On the other hand, neverdried BNC displays a remarkable biocompatibility. Despite this, all nanocelluloses clearly represent a flag bearer of future superior biomaterials, being
elite materials in the urgent replacement of our petrochemical dependence
Understanding the roles of glia and circulating leukocytes in neurodegenerative diseases
https://www.frontiersin.org/research-topics/11664/understanding-the-roles-of-glia-and-circulating-leukocytes-in-neurodegenerative-disease
- …